Pharma channel feed

Af­ter clear­ing an FDA hur­dle, Am­gen wins an FDA OK on CKD drug Parsabiv

9 years ago

Two friends and biotech col­leagues with a pas­sion for in­sid­er in­fo - feds charge Mer­ri­mack staffer

9 years ago

As hep C rev­enue dis­in­te­grates, pres­sure keeps grow­ing on Gilead to do deals

9 years ago

White House: Trump re­mains com­mit­ted to Medicare drug price ne­go­ti­a­tions

9 years ago

A swarm of top biotech ex­ecs protest against Trump’s trav­el ban, say­ing it threat­ens the en­tire in­dus­try

9 years ago
People

With Trump’s new FDA com­mish nom­i­nee loom­ing, in­dus­try ex­ecs are keep­ing their fin­gers crossed for Scott Got­tlieb

9 years ago

Biotech deal­mak­er Ra­maswamy rais­es an­oth­er $55M for Ax­o­vant

9 years ago
Financing

Cy­to­ki­net­ics chief Blum grabs $100M roy­al­ty deal to fund an ex­pand­ed mar­ket­ing plan for PhI­II heart drug

9 years ago

Big Phar­ma promised Trump new Amer­i­can jobs for tax cuts and dereg­u­la­tion. But the vow comes af­ter a 5-year purge

9 years ago

An­a­lysts write off Di­men­sion’s lead pro­gram af­ter see­ing weak da­ta on he­mo­phil­ia B, shares plunge

9 years ago

Trump scolds phar­ma ex­ecs, de­mand­ing low­er prices, more US man­u­fac­tur­ing while promis­ing to slash FDA regs

9 years ago

On a deal spree, Take­da grabs Japan­ese cabo rights in $145M pact with Ex­elix­is

9 years ago

Fi­bro­Gen, As­traZeneca ready Chi­na ap­pli­ca­tion as ane­mia drug scores in two piv­otal stud­ies

9 years ago
R&D
China

In­cyte grabs con­trol of a can­cer drug from Calithera’s pipeline for $53M up front

9 years ago

Biotech ex­ecs slam Trump’s trav­el ban, count­ing the high cost to a glob­al in­dus­try

9 years ago

End­points Video spot­light: The de­bate over drug pric­ing takes cen­ter stage in 2017

9 years ago

Ex­perts fret over a new hir­ing freeze at the FDA. Will the fall­out be tox­ic to drug re­views?

9 years ago

Ex-Mela chief Gul­fo joins the list of would-be FDA com­mish can­di­dates, col­or-cod­ed drug ap­proval plan in hand

9 years ago

Women are gain­ing more board seats in biotech, but re­al change is hap­pen­ing at a snail's pace

9 years ago
R&D

Banned from Twit­ter, Mar­tin Shkre­li whips up a new on­line tirade in re­sponse to a mock­ing dig from PhRMA chief

9 years ago

Fac­ing a deep­en­ing po­lit­i­cal cri­sis, PhRMA launch­es a ma­jor coun­ter­at­tack against its le­gion of crit­ics

9 years ago

Af­ter re­peat­ed set­backs on the check­point front, Bris­tol-My­ers scores a $625M pay­out from Mer­ck to set­tle patent fra­cas

9 years ago

The FDA’s cau­tion­ary Hall of Shame: 22 ‘break­through’ drugs that sud­den­ly crashed in PhI­II

9 years ago

Bris­tol-My­ers stag­gered by a stun­ning check­point set­back, hands Mer­ck a free pass on front­line lung can­cer com­bo

9 years ago
R&D
First page Previous page 333334335336337338339 Next page Last page
A service from the Financial Times